Market Overview - The Hong Kong stock index opened higher but showed mixed performance, with the Hang Seng Index up 0.18% at 25,848.99 points, the Hang Seng Tech Index down 0.42% at 5,503.87 points, the National Enterprises Index up 0.11% at 8,949.28 points, and the Red Chip Index up 0.39% at 4,091.24 points [1] - Major tech stocks exhibited varied movements, with Alibaba up 0.68%, Tencent down 1.46%, JD.com up 0.98%, Xiaomi down 1.66%, NetEase up 0.19%, Meituan up 0.39%, Kuaishou down 3.6%, and Bilibili up 0.41% [1] - Wind power stocks led the gains, with Dongfang Electric rising over 5%, while gold stocks continued their upward trend, with Shandong Gold also up over 5% [1] - The lithium battery sector saw significant increases, with Ganfeng Lithium up over 4%, and building materials and cement stocks remained active, with Dongwu Cement reaching a historical high [1] - Mobile game stocks, Apple concept stocks, and new energy vehicle companies mostly declined [1] - Newly listed company Relax Health saw a first-day increase of over 145%, while Nobi Kan surged 338.75% in half a day [1] Corporate News - Vanke Enterprises (02202.HK) extended the grace period for the principal and interest payment of its fourth phase of medium-term notes (total principal of 2 billion yuan) to 30 trading days [2] - Cathay Pacific (00293.HK) reported 2.5304 million passengers in November, a year-on-year increase of 26% [3] - Shanhigh New Energy (01250.HK) signed an EPC contract with China Railway 17th Bureau for a total price of 405.5 million yuan [3] - China General Nuclear Power (01816.HK) announced that the commissioning of Units 1 and 2 in Huizhou has been adjusted to the first half and second half of 2026, respectively [3] - Lehua Entertainment (02306.HK) entered into a business cooperation framework agreement with Youku Information Technology [4] - Xinyang Global Holdings (00723.HK) signed a cooperation agreement with Guangxi Fenglin (601996.SH) to jointly develop the EU wood board and related product market [4] - Tabo (06110.HK) reported a high single-digit year-on-year decline in total sales for its retail and wholesale business in Q3 of the 2025/26 fiscal year [4] - Dipo Technology (01384.HK) entered into a strategic cooperation agreement with Muxi Co., aiming to deepen their strategic partnership in enterprise-level large model AI applications [4] - He Yu-B (02256.HK) received approval from China's NMPA for its CSF-1R inhibitor Beijiemai® [5] - Saint Noble Pharmaceuticals-B (02257.HK) completed Phase I trials for its experimental drug STP707 and formally submitted a clinical research report to the FDA [6] - Nanshan Aluminum International (02610.HK) increased its annual production capacity for alumina to 4 million tons [7] - Rungo Interactive (02422.HK) plans to sell 75% of its stake in Xi'an Tiantai Innovation Technology Co., Ltd. for 11.3 million yuan [8] - China Tianhua Chemical (00362.HK) received guidance from the Hong Kong Stock Exchange for resuming trading, but remains suspended [9] Institutional Insights - Huatai Securities noted that the market is still in a left-side layout phase, with the right-side turning point not yet clear. There is strong consensus on an early spring rally, but year-end supply and demand pressures create uncertainty for a "Santa rally." The first quarter may present a higher probability phase for investment [10] - CITIC Securities observed that after a unilateral rise in September, the Hong Kong stock market has experienced fluctuations since October due to repeated overseas macro expectations. Quality assets in the Hong Kong market have re-entered a high cost-performance zone, and with continued northbound capital inflow and improved profit expectations, the market is entering a significant year-end trading window [10] - China Galaxy suggested focusing on the technology sector as a long-term investment theme, which is expected to rebound after previous adjustments. The consumer sector is anticipated to receive substantial policy support, with current valuations at relatively low levels, indicating significant long-term upside potential [11]

Company News - Vanke Enterprise (02202.HK) has extended the grace period for the principal and interest payment of its fourth tranche of medium-term notes (total principal of 2 billion yuan) to 30 trading days [1] - Cathay Pacific Airways (00293) reported a passenger count of 2.5304 million in November, representing a year-on-year increase of 26% [1] - Shandong High New Energy (01250.HK) announced that its subsidiary Wuxiang Beiqing Smart Energy has signed an EPC contract with China Railway 17th Bureau, with a total contract value of 405.5 million yuan [1] - China General Nuclear Power (01816) reported that the commissioning of Units 1 and 2 in Huizhou has been adjusted, with expected operational dates moved to the first half and second half of 2026, respectively [1] Strategic Partnerships - Lehua Entertainment (02306.HK) has signed a business cooperation framework agreement with Youku Information Technology and Youku for 2026 [2] - Xinbao Global Holdings (00723.HK) has entered into a cooperation agreement with Guangxi Fenglin (601996.SH) to jointly develop the EU wood board and related product market [2] - Dipo Technology (01384.HK) has established a strategic cooperation agreement with Muxi Co., aiming to deepen collaboration in enterprise-level large model AI applications across key industries such as manufacturing, commercial circulation, transportation, and healthcare [2] Product Development - He Yu-B (02256.HK) announced that its CSF-1R inhibitor Beijiemai® has received approval from China's NMPA [3] - Saint Noble Pharmaceuticals-B (02257.HK) has completed Phase I trials for its investigational drug STP707 and has formally submitted the clinical research report to the FDA [4] - Nanshan Aluminum International (02610.HK) has increased its annual production capacity for alumina to 4 million tons [5] Share Buybacks - Tencent Holdings (00700.HK) repurchased 1.035 million shares at a cost of 636 million HKD, with repurchase prices ranging from 610.5 to 620 HKD [8] - Xiaomi Group-W (01810.HK) spent approximately 149 million HKD to repurchase 3.75 million shares, with prices between 37.61 and 42.50 HKD [9] - Giant Bio (02367.HK) repurchased approximately 14.43 million HKD worth of 400,000 shares, with prices between 34.71 and 36.34 HKD [10]

Core Viewpoint - China Tianhua Chemical (00362.HK) has received guidance from the Stock Exchange regarding the resumption of trading of its shares, which includes several conditions that must be met by specified deadlines [1] Group 1: Resumption Guidelines - The company must revoke or dismiss any liquidation orders and remove any liquidators [1] - The company is required to demonstrate compliance with Listing Rule 13.24 [1] - The company must disclose all significant information to allow shareholders and investors to assess its condition [1] - The company is obligated to publish all outstanding financial results and resolve any audit revisions [1] Group 2: Trading Suspension and Delisting Risks - The Stock Exchange may delist securities that have been suspended for 18 months, with the deadline for China Tianhua Chemical being September 16, 2026 [1] - If the company fails to remedy the issues leading to the suspension and does not comply with the resumption guidelines by the deadline, the Listing Division will recommend delisting to the Listing Committee [1] - The Stock Exchange has the authority to impose a shorter remedial period if deemed appropriate [1]

Core Viewpoint - China Tianhua Chemical (00362) has received letters from the Stock Exchange regarding the resumption of trading of its shares, outlining specific conditions that must be met for the resumption to occur [1] Group 1 - The company must revoke or dismiss any liquidation orders against it and remove any liquidators [1] - The company is required to demonstrate compliance with Listing Rule 13.24 [1] - The company must disclose all significant information to allow shareholders and other investors to assess its condition [1] Group 2 - The company is obligated to publish all outstanding financial results in accordance with listing rules and address any audit revisions [1] - The company's shares remain suspended from trading [1]

Core Viewpoint - China Tianhua Chemical (00362) has received letters from the Stock Exchange regarding the resumption of trading of its shares, outlining specific conditions that must be met for the resumption to occur [1] Group 1: Resumption Conditions - The company must withdraw or dismiss any liquidation orders against it and remove any liquidators [1] - The company needs to demonstrate compliance with Listing Rule 13.24 [1] - The company is required to disclose all significant information to allow shareholders and other investors to assess its condition [1] - The company must publish all outstanding financial results in accordance with listing rules and resolve any audit revisions [1] Group 2: Current Status - The company's shares remain suspended from trading [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部分內容而產生或因依 賴該等內容而引致的任何損失承擔任何責任。 China Zenith Chemical Group Limited 中國天化工集團有限公司 （強制清盤中） （於開曼群島註冊成立並於百慕達存續之有限公司） （股份代號：362） (1) 最新發展之季度更新; 本公告乃中國天化工集團有限公司（強制清盤中）（「本公司」，連同其附屬公司統 稱「本集團」）根據香港聯合交易所有限公司（「聯交所」）證券上市規則（「上市 規則」）第 13.09 條及第 13.24A 條，以及香港法例第 571 章證券及期貨條例第XIVA部 之內幕消息條文（定義見上市規則）作出。 茲提述本公司日期分别為 2025 年 4 月 17 日及 2025 年 11 月 21 日的公告（「該等公 告」），其中包括對本公司作出的清盤令以及共同及各別清盤人的任命。除另界定外， 本公告所用詞彙與該等公告所界定者具有相同涵義。 最新發展之季度更新 誠如該等公告所述，根據高等法院於 2025 年 10 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年11月30日 狀態: 新提交 致：香港交易及結算所有限公司 II. 已發行股份及/或庫存股份變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) 是 | | | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00362 | 說明 | | | | | | | | 已發行股份（不包括庫存股份）數目 | | 庫存股份數目 | 已發行股份總數 | | | 上月底結存 | | | 1,351,548,168 | | 0 | 1,351,548,168 | | 增加 / 減少 (-) | | | | | | | | 本月底結存 | | | 1,351,548,168 | | 0 | 1,351,548,168 | 公司名稱: 中國天化工集團有限公司（於開曼群島註冊成立並於百慕達存續之有限公司） 呈交日期: 2025年12月1日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 ...

Core Viewpoint - China Tianhua Chemical (00362) has announced the appointment of joint and individual liquidators following a court order from the High Court dated October 31, 2025 [1] Group 1 - The joint and individual liquidators appointed are Mr. Ma De Min and Mr. Li Yong Lin from Kai Jin Enterprise Consulting Co., Ltd [1] - The appointment of the liquidators is effective from October 31, 2025, granting them authority as the company's representatives [1]

Core Viewpoint - China Tianhua Chemical (00362) has announced the appointment of joint and individual liquidators following a court order from the High Court dated October 31, 2025 [1] Group 1 - The joint and individual liquidators appointed are Mr. Ma Demin and Mr. Li Yung Lin from Kaijin Enterprise Consulting Co., Ltd [1] - The appointment of the liquidators is effective from October 31, 2025, granting them authority as the company's representatives [1]

Core Viewpoint - China Tianhua Chemical (00362.HK) has announced the appointment of joint and several liquidators following a court order, indicating significant corporate restructuring and potential insolvency issues [1] Group 1: Company Announcement - The High Court appointed Ma De Min and Li Ying Lin from Kai Jin Corporate Advisors Limited as joint and several liquidators of the company as of October 31, 2025 [1] - The company's executive director and authorized representative, Sheng Pin Ru, passed away on August 18, 2025 [1] - Trading of the company's shares has been suspended on the Hong Kong Stock Exchange since 10:28 AM on March 17, 2025, and will remain suspended until further notice [1]